Adapting the drivers to the road: a new strategy for cancer evolution?

Ann Oncol. 2015 May;26(5):827-829. doi: 10.1093/annonc/mdv137. Epub 2015 Mar 6.

Authors

M Touat¹, F Dhermain², F André³, M Sanson⁴

Affiliations

¹ Drug Development Department (DITEP); University Paris Sud, Inserm Unit U981.
² Department ofRadiation Oncology.
³ University Paris Sud, Inserm Unit U981; Department of Medical Oncology, Gustave Roussy, Villejuif.
⁴ AP-HP, Department of Neurology Mazarin, Pitié-Salpêtrière Hospital, Paris; University Sorbonne UPMC, Inserm Unit U1127, CNRS Unit UMR 7225, Brain & Spine Institute, Paris, France. Electronic address: marc.sanson@psl.aphp.fr.

PMID: 25748650
DOI: 10.1093/annonc/mdv137

No abstract available

Publication types

Editorial
Comment

MeSH terms

Carcinoma, Renal Cell / genetics*
Evolution, Molecular*
Genetic Heterogeneity*
Humans
Kidney Neoplasms / genetics*
Phenotype*